Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
450 participants
INTERVENTIONAL
2010-02-28
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multicenter Comparison of Early and Late Vascular Responses to Everolimus-eluting Cobalt-CHromium Stent and Platelet AggregatioN studIeS for TreatMent of Acute Myocardial InfarctionTreatment of ST-elevation Acute Myocardial Infarction
NCT02014753
Trial of MiStent Compared to Xience in Japan
NCT02972671
Drug-eluting Stents to Treat Unprotected Coronary Left Main Disease
NCT00598637
Comparison of the Everolimus Eluting With the Biolimus A9 Eluting Stent
NCT01233453
The Efficacy of Three Different Limus Agent-Eluting Stents to Prevent Restenosis
NCT00332397
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Single arm study
Intracoronary stent implantation
Everolimus-eluting stent implantation in patients with long coronary artery disease
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intracoronary stent implantation
Everolimus-eluting stent implantation in patients with long coronary artery disease
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Females who are not pregnant
3. Patients who present with angina symptoms or myocardial ischemia
4. Patients available for post-procedural observation and coronary angiography at 24 months
5. Patients who have signed patient informed consent
6. Lesion length is more than 30mm
7. De novo lesion or non-stented restenosed lesion
Exclusion Criteria
2. Patients with significant allergic reaction to contrast medium
3. Chronic total occlusion
4. Lesion with TIMI0
5. Patients with chronic renal failure (SCr\>3.0mg/dl) -
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Society for Advancement of Coronary Intervention Research
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Toyohashi Heart Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yuji Oikawa, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Cardiovascular institute hospital
Kenya Nasu, MD
Role: PRINCIPAL_INVESTIGATOR
Toyohashi Heart Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Japanese Red Cross Nagoya Daiichi Hospital
Nagoya, Aichi-ken, Japan
Toyohashi Heart Center
Toyohashi, Aichi-ken, Japan
Higashi Cardiovascular clinic
Toyohashi, Aichi-ken, Japan
Hiraka General Hospital
Yokote, Akita, Japan
Saiseikai Fukuoka General Hospital
Fukuoka, Fukuoka, Japan
Kokura memorial hospital
Kitakyushu, Fukuoka, Japan
Hoshi General Hospital
Kōriyama, Fukushima, Japan
Gunma Prefectural Cardiovascular Center
Maebashi, Gunma, Japan
Abashiri Kosei General Hospital
Abashiri, Hokkaido, Japan
Engaru-Kosei General Hospital
Engaru, Hokkaido, Japan
Hakodate Goryokaku Hospital
Hakodate, Hokkaido, Japan
Obihiro National Hospital
Obihiro, Hokkaido, Japan
Kinikyo Chuo Hospital
Sapporo, Hokkaido, Japan
Sapporo Orthopaedic Cardiovascular Hospital
Sapporo, Hokkaido, Japan
Shinko Kakogawa Hospital
Kakogawa, Hyōgo, Japan
Daini Okamoto Hospital
Uji, Kyoto, Japan
Miyagi Cardiovascular ＆ Respiratory Center
Kurihara, Miyagi, Japan
Matsumoto Kyoritsu Hospital
Matsumoto, Nagano, Japan
Rinku General Medical Center
Izumiōtsu, Osaka, Japan
Sakurabashi Watanabe Hospital
Osaka, Osaka, Japan
Kasukabe Chuo General Hospital
Kasukabe, Saitama, Japan
Shuwa General Hospital
Kasukabe, Saitama, Japan
Kusatsu Heart Center
Kusatsu, Shiga, Japan
Ayase Heart Hospital
Adachi City, Tokyo, Japan
Juntendo University Hospital
Bunkyo, Tokyo, Japan
Tokyo-kita Social Insurance Hospital
Kita-ku, Tokyo, Japan
Cardiovascular Institute Hospital
Minato-ku, Tokyo, Japan
JR Tokyo General Hospital
Shibuya City, Tokyo, Japan
Tokyo Medical University Hospital
Shinjuku, Tokyo, Japan
Itabashi Chuo Medical Center
tabashi City, Tokyo, Japan
Tokyo Metropolitan Police Hospital
Tokyo, Tokyo, Japan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
XILLION
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.